Allworth Financial LP Has $5.73 Million Stock Holdings in CME Group Inc. (NASDAQ:CME)

Allworth Financial LP lowered its position in shares of CME Group Inc. (NASDAQ:CME) by 5.0% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 25,953 shares of the financial services provider’s stock after selling 1,376 shares during the quarter. Allworth Financial LP’s holdings in CME Group were worth $5,727,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Oak Harvest Investment Services boosted its holdings in CME Group by 66.5% in the 1st quarter. Oak Harvest Investment Services now owns 45,093 shares of the financial services provider’s stock valued at $9,708,000 after purchasing an additional 18,017 shares during the period. Wealth Enhancement Advisory Services LLC increased its stake in CME Group by 21.2% during the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 48,205 shares of the financial services provider’s stock worth $9,477,000 after acquiring an additional 8,443 shares during the period. Duality Advisers LP acquired a new position in CME Group in the 1st quarter valued at $1,455,000. SG Americas Securities LLC lifted its position in shares of CME Group by 312.2% during the 1st quarter. SG Americas Securities LLC now owns 56,768 shares of the financial services provider’s stock valued at $12,222,000 after acquiring an additional 42,996 shares during the period. Finally, Cetera Investment Advisers grew its holdings in shares of CME Group by 429.1% during the 1st quarter. Cetera Investment Advisers now owns 47,521 shares of the financial services provider’s stock worth $10,231,000 after purchasing an additional 38,540 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

CME Group Stock Performance

Shares of CME Group stock opened at $226.14 on Friday. The business has a 50-day simple moving average of $218.94 and a 200 day simple moving average of $208.89. The firm has a market capitalization of $81.43 billion, a price-to-earnings ratio of 25.73, a PEG ratio of 7.76 and a beta of 0.55. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a one year low of $190.70 and a one year high of $230.36.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, topping analysts’ consensus estimates of $2.65 by $0.03. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The company had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same period in the prior year, the firm earned $2.25 earnings per share. CME Group’s revenue for the quarter was up 18.4% on a year-over-year basis. On average, research analysts anticipate that CME Group Inc. will post 10.04 earnings per share for the current fiscal year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th were paid a $1.15 dividend. This represents a $4.60 annualized dividend and a dividend yield of 2.03%. The ex-dividend date was Monday, September 9th. CME Group’s dividend payout ratio (DPR) is presently 52.33%.

Wall Street Analysts Forecast Growth

CME has been the subject of several recent analyst reports. Morgan Stanley upped their price objective on shares of CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 17th. Bank of America lifted their price objective on shares of CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a research note on Thursday, October 3rd. Barclays boosted their target price on CME Group from $219.00 to $231.00 and gave the stock an “equal weight” rating in a research note on Thursday. Oppenheimer lifted their price target on shares of CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a report on Thursday. Finally, Citigroup increased their price objective on shares of CME Group from $250.00 to $255.00 and gave the company a “buy” rating in a research note on Thursday. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat, CME Group has a consensus rating of “Hold” and an average price target of $222.07.

Insider Activity

In other CME Group news, CFO Lynne Fitzpatrick sold 754 shares of CME Group stock in a transaction on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the transaction, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at $2,877,504.39. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the sale, the director now directly owns 55,607 shares in the company, valued at approximately $11,932,706.13. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Lynne Fitzpatrick sold 754 shares of the company’s stock in a transaction on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the transaction, the chief financial officer now owns 13,261 shares of the company’s stock, valued at $2,877,504.39. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.30% of the company’s stock.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.